跳至主要内容
临床试验/NCT06275022
NCT06275022招募中不适用

A Prospective Randomized Controlled Study on the Treatment of Cystic Lymphatic Malformation Based on Indocyanine Green-fluorescence Imaging

Nanjing Children's Hospital1 个研究点 分布在 1 个国家目标入组 110 人开始时间: 2023年1月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
110
试验地点
1
主要终点
Treatment frequency

研究概览

简要总结

The goal of this prospective randomized controlled study is to explore the role of indocyanine green-fluorescence imaging in management of cystic lymphatic malformation.. To clarify the application value of indocyanine green-fluorescence imaging in both diagnosis and treatment of cystic lymphatic malformation (cLM) in children, is helpful for exploring pathogenesis of cLM, and providing a clearer scientific basis for subsequent surgical intervention. It also provides alternative for the future diagnosis and treatment of cLM.

Participants will receive indocyanine green-fluorescence imaging before operation, while the patients in control group will receive traditional operation.

Researchers will compare difference in curative effect between two groups.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
30 Days 至 16 Years(Child)
性别
All
接受健康志愿者

入选标准

  • (1) no previous intervention; (2) cLM diagnosed by pretreatment magnetic resonance imaging (MRI); (3)3 to 6 months post-treatment follow-up; (4) Superfacial cLM

排除标准

  • (1) history of iodine allergy; (2) syndromic cLM ; (3) severe liver and kidney dysfunction; (4) intralesional hemorrhage; (5) intralesional infection

研究组 & 干预措施

Macro/mixed cystic lymphatic A

Experimental

Inflow occlusion assisted by indocyanine green-fluorescence imaging combined with perforation of septation and sclerotherapy

干预措施: Inflow occlusion with perforation of septation and sclerotherapy (Procedure)

Macro/mixed cystic lymphatic B

Active Comparator

Perforation of septation and sclerotherapy

干预措施: Perforation of septation and sclerotherapy (Procedure)

Microcystic lymphatic A

Experimental

Indocyanine green-fluorescence imaging-guided partial resection and sclerotherapy

干预措施: Indocyanine green-guided partial resection and sclerotherapy (Procedure)

Microcystic lymphatic B

Active Comparator

Partial resection and sclerotherapy

干预措施: Partial resection and sclerotherapy (Procedure)

结局指标

主要结局

Treatment frequency

时间窗: 3 months, 6 months

Frequency of treatments

Cure rate

时间窗: 1month, 3 months

The percentage of cured cases to total cases

Effective rate

时间窗: 1 month, 3 months

The percentage of effective cases to total cases

次要结局

  • Likert score(6 months)
  • Wound infection(1 month)
  • Pigmentation(1 month)
  • Delayed healing(1 month)

研究者

发起方
Nanjing Children's Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Tao Han

Dr.

Nanjing Children's Hospital

研究点 (1)

Loading locations...

相似试验